Nirvana Life Sciences (XCNQ:NIRV.X) EPS (Basic): C$0.01 (TTM As of Jan. 2026)


What is Nirvana Life Sciences EPS (Basic)?

Nirvana Life Sciences XCNQ:NIRV.X EPS (Basic) is C$0.01 as of Jan. 2026. The stock has 3 warning signs investors should review.

Nirvana Life Sciences's basic earnings per share (Basic EPS) for the three months ended in Jan. 2026 was C$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2026 was C$0.01.

Nirvana Life Sciences's EPS (Diluted) for the three months ended in Jan. 2026 was C$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2026 was C$0.01.

Nirvana Life Sciences's EPS without NRI for the three months ended in Jan. 2026 was C$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2026 was 0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Nirvana Life Sciences  (XCNQ:NIRV.X) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Nirvana Life Sciences EPS (Basic) Related Terms

Nirvana Life Sciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences EPS (Basic) Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
EPS (Basic)
Get a 7-Day Free Trial -0.08 -1.60 -0.40 -0.19 -0.08

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 0.02 -0.01 0.00 0.00

Nirvana Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Nirvana Life Sciences's Basic EPS for the fiscal year that ended in Apr. 2025 is calculated as

Basic EPS (A: Apr. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.366-0)/4.823
=-0.08

Nirvana Life Sciences's Basic EPS for the quarter that ended in Jan. 2026 is calculated as

Basic EPS (Q: Jan. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.053-0)/22.823
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$0.01 mean?
Nirvana Life Sciences (XCNQ:NIRV.X) has a EPS (Basic) of C$0.01 as of Jan. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Nirvana Life Sciences and its competitors.
Is Nirvana Life Sciences' EPS (Basic) too high?
Nirvana Life Sciences' current EPS (Basic) is C$0.01.
How does Nirvana Life Sciences' EPS (Basic) compare to VRTX and REGN?
Nirvana Life Sciences' EPS (Basic) of C$0.01 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current EPS (Basic) is C$0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (XCNQ:NIRV.X) has a current EPS (Basic) of C$0.01. The current EPS (Basic) is C$0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Nirvana Life Sciences (XCNQ:NIRV.X), the current EPS (Basic) is C$0.01 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.